<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8237">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01915004</url>
  </required_header>
  <id_info>
    <org_study_id>Bladder Training Video</org_study_id>
    <nct_id>NCT01915004</nct_id>
  </id_info>
  <brief_title>The Effectiveness of a Bladder Training Video for Management of Lower Urinary Tract Symptoms.</brief_title>
  <official_title>Bladder Training Video Versus Individual Urotherapy for Children With Non-neurogenic Lower Urinary Tract Dysfunction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Urological Association</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children with non-neurogenic lower urinary tract dysfunction (NLUTD) represent a significant
      subgroup of pediatric urology patients, comprising up to 30 percent of some out-patient
      clinics. These children present with urinary tract infections (UTIs), abnormal voiding
      habits and various other lower urinary tract symptoms (LUTs) such as incontinence, urinary
      urgency and urinary frequency. Furthermore, the effects of NLUTD on a child's physcial
      health, mental health and its potential negative clinical sequelae, which includes upper or
      lower urinary tract damage, must be taken into account when treating these children. These
      patients have complex needs requiring a significant amount of health teaching and it is
      imperative to determine the effectiveness of the various modes of delivering urotherapy. To
      determine the best modality to deliver urotherapy, this trial will compare the effectiveness
      of a 15 minute  bladder training video to the effectiveness of standard urotherapy provided
      at a pediatric urology clinic at improving NLUTD/DES symptoms and quality of life in
      children between 6-10 years of age.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Improvement of Nonneurogenic Lower Urinary Tract Dysfunction symptoms</measure>
    <time_frame>up to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determine improvement of Nonneurogenic Lower Urinary Tract Dysfunction symptoms according to the Vancouver NLUTD/DES questionnaire after administration of either intervention (Bladder Training Video or standard urotherapy)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the Quality of Life of children with Nonneurogenic Lower Urinary Tract Dysfunction/Dysfunctional Elimination Syndrome.</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The secondary outcome is to assess the QOL of children with NLUTD/DES.  QOL will be measured by a validated QOL tool specific to children with bladder dysfunction called the PinQ</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nonneurogenic Lower Urinary Tract Dysfunction</condition>
  <condition>Dysfunctional Elimination Syndrome</condition>
  <arm_group>
    <arm_group_label>Standard Invididual Urotherapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Educational Intervention. Standard individual urotherapy (bladder re-training) occurs in the pediatric urology clinic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bladder Training Video</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental Educational Intervention. Participants will watch a 15 minute animated bladder training video.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Intervention</intervention_name>
    <description>Bladder Training Video</description>
    <arm_group_label>Standard Invididual Urotherapy</arm_group_label>
    <arm_group_label>Bladder Training Video</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 6-10 years old

          -  Bladder Dysfunction (Diagnosis of NLUTD or DES)

        Exclusion Criteria:

          -  Grade 3 or 4 hydronephrosis

          -  Grade 3, 4 or 5 vesicoureteral reflux

          -  Other diagnoses which affect bladder bowel function (i.e. Spina Bifida)

          -  English as a second language

          -  Diagnosed learning disability (i.e. ADD or ADHD)

          -  Mental health condition (i.e. anxiety or depression)

          -  Received urotherapy in past 24 months
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis Braga, MD, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luis Braga, MD, FRCSC</last_name>
    <phone>9055212100</phone>
    <phone_ext>73777</phone_ext>
    <email>braga@mcmaster.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia Pemberton, MSc. PhD (c)</last_name>
    <phone>9055212100</phone>
    <phone_ext>76692</phone_ext>
    <email>pemberj@mcmaster.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4K1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>, MD,</last_name>
    </contact>
    <investigator>
      <last_name>Luis Braga, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge DeMaria, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natasha Brownrigg, RN, MN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 31, 2013</lastchanged_date>
  <firstreceived_date>July 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pediatric Urology</keyword>
  <keyword>Urotherapy</keyword>
  <keyword>Nonneurogenic Lower Urinary Tract Dysfunction</keyword>
  <keyword>Dysfunctional Elimination Syndrome</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
